Researchers say this new Trump rule could destroy American science as we know it. They’re fighting back

Scientists Warn of Threat to U.S. Scientific Leadership as Trump Administration Proposes New Funding Rule

Researchers say this new Trump rule – In a sweeping move that has sparked widespread concern, the White House has unveiled a proposed rule aimed at reshaping the way scientific research is funded across federal agencies. The Office of Management and Budget (OMB) is seeking greater authority over grant approvals, shifting decision-making power to political appointees rather than relying on the traditional peer review process. Researchers from diverse fields, including climate science, oncology, and biomedical studies, are now sounding the alarm over the potential consequences of this policy shift. They argue that it could fundamentally alter the landscape of American research and weaken the nation’s scientific dominance on the global stage.

A Shift in Federal Grant Oversight

The rule, which is currently under review, would replace the longstanding peer review system with a model that prioritizes political input. This system, which has been in place since the post-World War II research boom, has long been a cornerstone of U.S. scientific advancement. It involves panels of experts assessing the merit of grant applications based on objective criteria, ensuring that the most promising research ideas receive funding. Critics fear that the new approach could introduce bias, favoring projects aligned with the administration’s priorities over those driven by scientific curiosity or discovery.

One of the most controversial aspects of the proposal is its potential to eliminate research on topics such as diversity, equity, and inclusion. Additionally, it would curtail studies focused on gender and interrupt collaborations with international scientific partners. These changes are seen as a direct challenge to the openness and neutrality that have defined U.S. research for decades. “This rule could signal a new era where politics dictates which questions are worth exploring,” said Lisa Larrimore Ouellette, a Stanford Law School professor and prominent voice in the debate. She emphasized that the shift might not only affect climate science but also ripple through other disciplines, including social sciences and public health.

Defending the Rule: Transparency and Fiscal Responsibility

OMB officials defend the proposal as a necessary step to ensure accountability in federal spending. They argue that the current peer review system has allowed for excessive bureaucratic delays and that political oversight would streamline decisions. “This rule brings transparency to the grantmaking process and ensures taxpayer dollars are used effectively,” stated an OMB spokesperson. “Federal grants have been politicized to advance a far-left agenda, and that trend will now be reversed.”

However, scientists counter that the rule is more than a procedural adjustment—it represents a strategic effort to reshape the research agenda. Kate Marvel, a climate scientist who recently departed from NASA due to political interference in her field, called the system a “deeply stupid” attempt to politicize science. “Peer review has been the backbone of American scientific leadership,” she explained. “It’s what allowed breakthroughs in cancer treatment, HIV research, and climate modeling to flourish. By replacing this with political criteria, we risk stifling innovation and losing our edge in global science.”

Public Comments and Congressional Review

As with any federal regulation, the OMB proposal is currently open for public input. This period has become a critical battleground for researchers, academic institutions, and advocacy groups seeking to sway the final decision. Many are leveraging the opportunity to submit comments in hopes of triggering a Congressional review, which could provide a final check on the rule’s implementation.

Elizabeth Ginexi, a former senior program officer at the National Institutes of Health (NIH), highlighted the urgency of the situation. “The goal is to mobilize as many supporters as possible—scientists, patient advocates, and anyone passionate about research—to flood the docket with feedback,” she said. Ginexi left the NIH after over two decades, citing the Trump administration’s aggressive budget cuts and its push to replace scientific oversight with politically motivated appointments. “The system wasn’t perfect, but it worked,” she noted. “Now, it’s under threat from people who don’t understand the complexities of scientific inquiry.”

Experts warn that the changes could have far-reaching effects. For instance, clinical trials for rare diseases might be sidelined if their focus on genetic diversity or social determinants of health is deemed politically irrelevant. Similarly, climate studies could face scrutiny if their findings challenge the administration’s environmental policies. “The peer review process was designed to evaluate research based on its scientific merit, not its political alignment,” said Marvel. “This rule risks creating a system where the most impactful studies are overlooked simply because they don’t fit the current narrative.”

Impact on Addiction Research and Global Collaboration

Diane Fishbein, a senior scientist at the University of North Carolina and spokesperson for the Addiction Science Defense Network, stressed the real-world implications of the rule. “If this passes, we’ll see a surge in addiction and overdose cases,” she warned. Fishbein pointed to the importance of research that examines how race, ethnicity, and gender influence substance use patterns. “Eliminating this work isn’t just an academic issue—it’s a public health crisis waiting to unfold.”

Moreover, the rule could disrupt international scientific partnerships, which have been vital for advancing global challenges like climate change and infectious disease control. Federally funded collaborations with foreign institutions often rely on open-access funding and shared expertise, but the new framework might prioritize domestic interests, limiting the scope of cross-border innovation. “We’re not just funding science in America—we’re building bridges with the world,” Ginexi added. “Cutting these ties could isolate the U.S. from critical global research efforts.”

Scientists Mobilize Against the Rule

Despite the OMB’s arguments, the scientific community remains divided. While some support the move toward more streamlined decision-making, others view it as a direct assault on the independence of research. “This isn’t just about funding—it’s about control,” said Ouellette. “If political appointees decide which studies are worthy of support, the integrity of science itself is at risk.”

Scientists are also highlighting the historical significance of the peer review system. For over 70 years, it has been the primary mechanism for allocating federal research dollars, ensuring that the most promising ideas—regardless of political leanings—are given a chance to develop. “Peer review is a democratic process that empowers scientists to evaluate each other’s work,” Marvel said. “It’s not a perfect system, but it’s the closest thing we have to a fair and efficient way of advancing knowledge.”

As the public comment period continues, the outcome of this debate will shape the future of U.S. research. With the stakes so high, scientists are fighting to protect a system that has fueled medical breakthroughs, technological innovations, and a deeper understanding of the natural world. “We’re not just defending the status quo—we’re fighting for the future of discovery,” Ginexi concluded. “If we lose this, the consequences will be felt for generations.”

With the rule still in flux, the scientific community remains vigilant, preparing for the next steps in a battle that could redefine the role of politics in research. Whether the changes will lead to greater efficiency or a deeper crisis in scientific credibility depends on how the debate unfolds in the coming weeks.